SHA:603392 Market Cap

SHA:603392 has a market cap or net worth of 51.83 billion as of February 27, 2026. Its market cap has decreased by -40.29% in one year.

Market Cap

51.83B

Enterprise Value

47.26B

Revenue

1.80B

Ranking

n/a

PE Ratio

n/a

Stock Price

40.99

Market Cap Chart

Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 51.83B, an increase of 848.64%. That is a compound annual growth rate of 47.07%.

Market Cap History

Date	Market Cap	% Change
Feb 26, 2026	51.12B	-10.04%
Dec 31, 2025	56.82B	-36.26%
Dec 31, 2024	89.14B	-6.44%
Dec 29, 2023	95.28B	-17.00%
Dec 30, 2022	114.80B	-14.62%
Dec 31, 2021	134.46B	53.87%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Apr 29, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haisco Pharmaceutical Group	52.57B
Pharmaron Beijing	50.38B
Hebei Changshan Biochemical Pharmaceutical	42.86B
Shanghai Allist Pharmaceuticals	42.47B
Chongqing Zhifei Biological Products	42.08B
Shanghai RAAS Blood Products	41.61B
Sunshine Guojian Pharmaceutical (Shanghai)	39.05B
Asymchem Laboratories (Tianjin)	35.03B

Market Cap Rankings